RFA NOW AVAILABLE
The Washington University Implementation Science Center for Cancer Control (WU-ISC3) is soliciting applications for Pilot and Methods Studies. The purpose of this small grants program is to advance the mission of the WU-ISC3. Our center strives to conduct research to eliminate the disparities in cancer outcomes in Missouri and Illinois. We achieve this through research that expedites proven interventions into real-world practice. Our vision is to commit our expertise in the fight against inequitable outcomes in our region. In particular, we are interested in studies that address health equity across a range of settings and populations.
Two types of implementation science projects will be funded:
1) Implementation Science Pilot Grants: These awards may be funded for either 1 year or 2 years. For 1-year projects, up to $75,000 direct costs are available. For 2-year projects, up to $60,000 direct costs per year are available (total direct costs, up to $120,000 for 2 years).These awards support the planning of a new clinical, community, or policy implementation science research project related to cancer control. Pilot grants are typically used to fund developmental or early stage work and should describe a concrete plan for further steps beyond the pilot grant (e.g., how the pilot work will lead to an R01 award). Pilot grants should address cancer prevention control related topics; preference will be given to topics identified from our community partners (see Attachment A). We highly encourage proposals to include community-based personnel as active members of the research team beyond a typical advisory role.
2) Implementation Science Methods Grants: These awards may be funded for either 1 year or 2 years. For 1-year projects, up to $60,000 direct costs are available. For 2-year projects, up to $50,000 direct costs per year are available (total direct costs, up to $100,000 for 2 years). Methods studies may involve a range of topics including: developing and adapting measures, applying mixed-methods, developing new methods for engaging community stakeholders, and applying innovative study designs or analytic technologies in D&I science. Methods studies may be informed by gaps identified by the WU-ISC3 Methods Unit and community partners (see Attachment A).
We will support a range of studies across the cancer control continuum from prevention, to screening, treatment, survivorship and end-of-life care. Studies should produce some “public good” (e.g., toolkits, enhanced capacity).
Both Pilot Grants and Methods Grants should address the following program considerations:
Key Element: Health equity
All applications should address the intersection of health equity and implementation science. To be responsive to this funding program, proposals must include methods and approaches to enhance health equity and reduce disparities in cancer and related conditions. Details on how our review criteria will address health equity can be found in Attachment B.
Key Element: Responsiveness to community needs
Projects should also have a focus on responsive research that is: 1) relevant to the needs of one or more stakeholders/partners (e.g., important, fills a need in practice and/or policy), 2) builds on input from stakeholders and community members (e.g., from our Think Tanks, Incubator survey, community input from earlier pilot and method studies), 3) builds on research showing gaps in the methods literature, and 4) brings in new partners and scholars, adding new disciplines and sectors (outside of traditional health settings). To ensure new partners and sectors are engaged, we aim to fund at least half of the studies with a focus on engaging settings and partners outside of health (e.g., schools, worksites, community-based organizations, policy settings). Innovative cross-disciplinary linkages and high-risk/high-reward studies designed to advance innovative implementation science are particularly encouraged. We seek to invest in partner-centered activities that solve a real-world problem within the WU-ISC3 network of stakeholders.
SUBMISSION AND REVIEW PROCESS
Letters of Intent due September 27, 2021 by 5pm CT
- LOIs are reviewed for relevance and feasibility. Invitation to submit a full proposal will be given by Oct. 25th
Full Proposals due December 6, 2021 by 5pm CT
- Details on materials to include proposal can be find in the linked RFA below
Award Start Date: All funds will be awarded by March 1, 2022; some funds may be dispersed earlier based on scope of a project and availability of funds.
More details and application instructions can be found in the following:
- Fall 2021 Full Research Funding Announcement
- Attachment A: Research Priorities
- Attachment B: Health Equity Resources
Contact our Center Manager, Maggie Padek, firstname.lastname@example.org